Maternal and Fetal Hemodynamic Adaptations to Pregnancy and Clinical Outcomes in Maternal Cardiac Disease

被引:6
|
作者
Ducas, Robin [1 ]
Saini, Brahmdeep S. [2 ,3 ]
Yamamura, Kenichiro [1 ]
Bhagra, Catriona [1 ]
Marini, Davide [2 ,4 ]
Silversides, Candice K. [1 ,5 ]
Roche, S. Lucy [1 ]
Colman, Jack M. [1 ,5 ]
Kingdom, John C. [5 ]
Sermer, Mathew [5 ]
Hanneman, Kate [1 ,6 ]
Seed, Mike [2 ,3 ,4 ]
Wald, Rachel M. [1 ,2 ,5 ,6 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Peter Munk Cardiac Ctr, Toronto Congenital Cardiac Ctr Adults, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Cardiol,Labatt Family Heart Ctr, Toronto, ON, Canada
[3] Univ Toronto, Inst Med Sci, Temerty Fac Med, Toronto, ON, Canada
[4] Univ Toronto, Dept Diagnost Imaging, Hosp Sick Children, Toronto, ON, Canada
[5] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada
[6] Univ Toronto, Joint Dept Med Imaging, Toronto, ON, Canada
关键词
CONTRAST MAGNETIC-RESONANCE; HEART-DISEASE; QUANTIFICATION; VOLUME; WOMEN; RISK; FLOW; AGE;
D O I
10.1016/j.cjca.2021.06.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although insufficient maternal cardiac output (CO) has been implicated in poor outcomes in mothers with heart disease (HD), maternal-fetal interactions remain incompletely understood. We sought to quantify maternal-fetal hemodynamics with the use of magnetic resonance imaging (MRI) and explore their relationship with adverse events. Methods: Pregnant women with moderate or severe HD (n = 22; mean age 32 +/- 5 years) were compared with healthy control women (n = 21; 34 +/- 3 years). An MRI was performed during the third trimester at peak output (maternal-fetal) and 6 months postpartum with return of maternal hemodynamics to baseline (reference). Phase contrast MRI was used for flow quantification and was combined with T1/T2 relaxometry for derivation of fetal oxygen delivery/consumption. Results: Third-trimester CO and cardiac index (CI) measurements were similar in HD and control groups (CO 7.2 +/- 1.5 vs 7.3 +/- 1.6 L/ min, P = 0.79; CI 4.0 +/- 0.7 vs 4.3 +/- 0.7 L/min/m,(2) P = 0.28). However, the magnitude of CO/CI increase (Delta, peak pregnancy reference) in the HD group exceeded that in the control group (CO 46 +/- 24% vs 27 +/- 16% [P = 0.007]; CI 51 +/- 28% vs 28 +/- 17% [P = 0.005]). Fetal growth and oxygen delivery/consumption were similar between groups. Adverse cardiovascular outcomes (non mutually exclusive) in 6 HD women included arrhythmia (n = 4), heart failure (n = 2), and hypertensive disorder of pregnancy (n = 1); premature delivery was observed in 2 of these women. The odds of a maternal cardiovascular event were inversely associated with peak CI (odds ratio 0.10, 95% confidence interval 0.001-0.86; P = 0.04) and D,CI (0.02, 0.001-0.71; P = 0.03). Conclusions: Maternal-fetal hemodynamics can be well characterised in pregnancy with the use of MRI. Impaired adaptation to pregnancy in women with HD appears to be associated with development of adverse outcomes of pregnancy.
引用
收藏
页码:1942 / 1950
页数:9
相关论文
共 50 条
  • [11] Maternal and Fetal Outcomes in Adult Congenital Heart Disease
    Venkataramani, Ranjani
    Lewis, Alexander E.
    Santos, Joshua I.
    Dhondu, Harsha S.
    Ramakrishna, Harish
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (09) : 3676 - 3684
  • [12] Maternal age as a risk factor for pregnancy outcomes: Maternal, fetal and neonatal complication
    Aghamohammadi, Azar
    Nooritajer, Maryam
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (02): : 264 - 269
  • [13] Clinical outcomes and predictors of fetal and maternal consequences of pregnancy in lupus nephritis patients
    Lv, Jiaxuan
    Wang, Wei
    Li, Yuehong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (08) : 1379 - 1385
  • [14] Neonatal and maternal outcomes of pregnancy with maternal cardiac disease (the NORMANDY study) : Years 2000-2014
    Bonnet, Vincent
    Simonet, Therese
    Labombarda, Fabien
    Dolley, Patricia
    Milliez, Paul
    Dreyfus, Michel
    Hanouz, Jean-Luc
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2018, 37 (01) : 61 - 65
  • [15] Pregnancy with Heart Disease: Maternal Outcomes and Risk Factors for Fetal Growth Restriction
    Thang Nguyen Manh
    Nhon Bui Van
    Huyen Le Thi
    Long Vo Hoang
    Hao Nguyen Si Anh
    Huong Trinh Thi Thu
    Thuc Nguyen Xuan
    Nga Vu Thi
    Le Bui Minh
    Dinh-Toi Chu
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (12)
  • [16] Maternal Vitamin D Levels During Pregnancy and Their Effects on Maternal-Fetal Outcomes: A Systematic Review
    Gilani, Samreen
    Janssen, Patricia
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2020, 42 (09) : 1129 - 1137
  • [17] PREGNANCY OUTCOMES OF 115 CASES WITH MATERNAL HEART DISEASE
    Ozel, Aysegul
    Hamzaoglu, Kubra
    Durmaz, Eser
    Madazli, Riza
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2020, 83 (01): : 17 - 22
  • [18] MATERNAL AND FETAL OUTCOMES IN PREGNANCY FOLLOWING BARIATRIC SURGERY
    Gonzalez Navarro, I.
    Pereira Cunill, J. L.
    Serrano Aguayo, P.
    Morales Conde, S.
    Martos Martinez, J. M.
    Garcia Luna, P. P.
    NUTRICION HOSPITALARIA, 2011, 26 (02) : 376 - 383
  • [19] Adverse pregnancy outcomes and future maternal cardiovascular disease
    Hauspurg, Alisse
    Ying, Wendy
    Hubel, Carl A.
    Michos, Erin D.
    Ouyang, Pamela
    CLINICAL CARDIOLOGY, 2018, 41 (02) : 239 - 246
  • [20] Effect of celiac disease on maternal and neonatal outcomes of pregnancy
    Elliott, Brittney
    Czuzoj-Shulman, Nicholas
    Spence, Andrea R.
    Mishkin, Daniel S.
    Abenhaim, Haim Arie
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (13): : 2117 - 2123